Therapy Areas
14 October 2019 - Swedish medical company OssDsign AB (publ) reported on Friday the receipt of US Food and Drug Administration (FDA) 510(k) clearance (K190523) to market its Cranial PSI Accessories in the US.The company said the Cranial PSI Accessori...
14 October 2019 - Eye care software company Topcon Healthcare Solutions revealed on Friday that it has signed a partnership to support the transition plan of IBM Watson Health Imaging's Merge Eye Station digital fundus imaging platform and Merge...
14 October 2019 - United States-based Gilead Sciences and Belgium-based Galapagos NV have revealed the Week 52 data from the registrational Phase 3 FINCH 1 and FINCH 3 trials of filgotinib, an investigational, oral, selective JAK1 inhibitor, intended...
11 October 2019 - - US-based skin cancer diagnostics company Castle Biosciences, Inc. (NASDAQ: CSTL) is highlighting the publication of an expert panel consensus statement that includes appropriate use criteria for DecisionDx-Melanoma in patients wit...
11 October 2019 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has hired Merdad Parsey, MD, PhD as chief medical officer, effective November 1, the company said.

Parsey will be responsible for the company...
11 October 2019 - - US-based ophthalmic pharmaceutical company Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has appointed Charlene E. Davis, Esq., as vice president and chief compliance officer, reporting to John LaRocca, Aerie's general counsel, ...
11 October 2019 - - US-based biotechnology company Advaxis, Inc. (NASDAQ: ADXS) has released updated median overall survival data from its Phase 1/2 KEYNOTE-046 study in metastatic, castration-resistant prostate cancer (mCRPC), the company said.